Toshio Kitawaki

13PUBLICATIONS
45CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 03, 2026
Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias.

|Aug 11, 2025
Prolonged chimeric antigen receptor-T apheresis to infusion time is associated with inferior outcomes in diffuse large B-cell lymphoma.

Suguru Morimoto, Tomoyasu Jo, Toshio Kitawaki

|Jul 09, 2025
Consistent ex vivo cell proliferation during manufacturing predicts favourable outcomes post-CAR-T-cell therapy.

Tomoyasu Jo, Yasuyuki Arai, Tomoshige Shimizu

|Dec 18, 2024
Fluctuation of physical function during chimeric antigen receptor T-cell therapy during rehabilitation intervention: Real-world data and risk factor analyses.

Ryota Hamada, Yasuyuki Arai, Toshio Kitawaki

|Dec 17, 2024
CAR T Cell Nanosymbionts: Revealing the Boundless Potential of a New Dyad.

Juan C Baena, Lucy M Pérez, Alejandro Toro-Pedroza

|Mar 03, 2022
Coexistence of HLA and KIR ligand mismatches as a risk factor for viral infection early after cord blood transplantation.

Tomoki Iemura, Yasuyuki Arai, Toshio Kitawaki

Pageof 3

Frequent Collaborators

7 joint publications

Junya Kanda

7 joint publications

Yasuyuki Arai

5 joint publications

Akifumi Takaori-Kondo

5 joint publications

Tomoyasu Jo